Lipoprotein(a), PCSK9 Inhibition and cardiovascular risk: Insights from the Fourier trial

Authors :: Michelle L. O'Donoghue
Marc Sabatine
KyungAh Im
Anthony C Keech
Ransi Somaratne
T. Pederson
Robert P. Giugliano
Estella Kanevsky
Peter S. Sever
A.Lira Pineda
Source :: Atherosclerosis. 275:e9-e10
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: medicine.medical_specialty
biology
business.industry
PCSK9
Lipoprotein(a)
030204 cardiovascular system & hematology
03 medical and health sciences
symbols.namesake
0302 clinical medicine
Fourier transform
Endocrinology
Internal medicine
symbols
biology.protein
Medicine
030212 general & internal medicine
Cardiology and Cardiovascular Medicine
business

Tools